Serial Number:
87899064
Mark:
NTX
Status:
Registered
Status Date:
01-21-2020
Filing Date:
Registration Number:
5968170
Registration Date:
01-21-2020
Custom manufacturer of pharmaceutical and biopharmaceutical compounds, namely, antibiotics, proteins, vaccines, enzymes, and small molecules Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, antibiotics, vaccines generated in a cell-free protein synthesizing system, antibiotics generated in a cell-free protein synthesizing system, proteins generated in a cell-free protein synthesizing system, and enzymes generated in a cell-free protein synthesizing system; research and development in the field of bioinformatics and production of proteins in cell-free systems for the development of vaccines, and antibiotics; medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use; research and development of new biological products for therapeutic use; research and development of antibiotic compounds for therapeutic use; research and development of methods of high-throughput screening of biological materials; research and development of methods of rapid-prototyping of biological materials; research and development of methods of real-time metabolic profiling of bacteria, fungi and plants to discover, characterize and produce bioactive products; design and development of nucleic acids, proteins, enzymes, antibiotic compounds, and drug compounds for use in pharmaceuticals, biotechnology, and medical and diagnostic applications using predictive bioinformatics; bioinformatics scientific research services, namely, identifying new drug compounds from analysis of genomic data
Mark Description:
N/A
Class:
Scientific and technological services
Type of Mark:
Servicemark
Published for Opposition Date:
04-09-2019
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
BERG HILL GREENLEAF RUSCITTI LLP
Correspondent Name: